Emiel De Jaeghere
- ORCID iD
- 0000-0001-6314-6179
Show
Sort by
-
- Journal Article
- open access
Identification of potentially actionable genetic variants in epithelial ovarian cancer: a retrospective cohort study.
-
A breath of relief : navigating the resolution of unexplained respiratory failure
-
Vaginal morbidity, sexual functioning, and health-related quality of life in cervical cancer survivors : a cross-sectional multicenter study (VAMOS)
-
Performance of MRI for detection of >=T1b disease in local staging of endometrial cancer
-
- Journal Article
- A1
- open access
Completion surgery after intensity-modulated arc therapy for locally advanced cervical cancer : long-term follow-up and update on surgical outcome and oncologic results of a unique tertiary care single-center retrospective cohort
-
- Journal Article
- A1
- open access
Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma : results of the phase II PRIMMO study
-
2022-RA-638-ESGO Pembrolizumab with multimodal immunomodulation in chemotherapy-pretreated cervical, endometrial, and uterine cancer : the PRIMMO phase II trial
(2022) INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. In International Journal of Gynecological Cancer 32(Supplement 2). p.A187-A188 -
- Journal Article
- A1
- open access
Mental health and quality of life among patients with cancer during the SARS-CoV-2 pandemic : results from the longitudinal ONCOVID survey study
-
Pembrolizumab, SBRT, and immunomodulation for recurrent and/or refractory cervical or endometrial carcinoma
-
- Journal Article
- A1
- open access
Risk of thrombo-embolic events in ovarian cancer : does bevacizumab tilt the scale? A systematic review and meta-analysis
-
How are OCD patients and family members dealing with the waxing and waning pattern of the COVID-19 pandemic? Results of a longitudinal observational study
-
Splenic hematopoietic and stromal cells in cancer progression
-
Splenic 18F-FDG uptake on baseline PET/CT is associated with oncological outcomes and tumor immune state in uterine cervical cancer
-
Immunologic impact of chemoradiation in cervical cancer and how immune cell infiltration could lead towards personalized treatment
-
- Journal Article
- A1
- open access
The nocebo effect and tobacco control : first, do no harm?
-
Immunologic impact of chemoradiation in cervical cancer and how immune cell infiltration could lead towards personalized treatment
-
Is locally advanced cervix adenocarcinoma less radiosensitive than squamous cell carcinoma?
-
Fibroblasts fuel immune escape in the tumor microenvironment
-
Morphological effects of chemoradiation therapy on cervical adenocarcinoma
-
Splenic metabolic activity as biomarker in cervical cancer
-
Treatment of ovarian cancer with intraperitoneal platinum : heating up the debate
-
- Journal Article
- A1
- open access
PRIMMO study protocol : a phase II study combining PD-1 blockade, radiation and immunomodulation to tackle cervical and uterine cancer
-
Tumor engineering a clinical relevant model that recapitulates the tumor environment of peritoneal metastases in vitro and in vivo
-
- Journal Article
- A1
- open access
Neo-adjuvant treatment of adenocarcinoma and squamous cell carcinoma of the cervix results in significantly different pathological complete response rates
-
Heterocellular 3D scaffolds as biomimetic to recapitulate the tumor microenvironment of peritoneal metastases in vitro and in vivo
-
Heterocellular 3D scaffolds as biomimetic to recapitulate the tumor microenvironment of peritoneal metastases in vitro and in vivo
-
Heterocellular 3D scaffolds as biomimetic of peritoneal metastasis in vitro and in vivo
-
Heterocellular 3D scaffolds as biomimetic of peritoneal metastasis in vitro and in vivo
-
- Conference Paper
- C3
- open access
Heterocellular 3D scaffolds as biomimetic of peritoneal metastases
-
- Conference Paper
- C3
- open access
Heterocellular 3D scaffolds as biomimetic of peritoneal metastasis in vitro and in vivo
-
- Conference Paper
- C3
- open access
In vivo visualisation of vessel formation in peritoneal tumour scaffolds with μCT
(2017) -
Tumour tissue transport after intraperitoneal anticancer drug delivery
-
Incorporating PARP-inhibitors into clinical routine : a tailored treatment strategy to tackle ovarian cancer